Cargando…

Neuroprotective Activity of Enantiomers of Salsolinol and N-Methyl-(R)-salsolinol: In Vitro and In Silico Studies

[Image: see text] Salsolinol (1-methyl-1,2,3,4-tetrahydroisoquinoline-6,7-diol) is a close structural analogue of dopamine with an asymmetric center at the C1 position, and its presence in vivo, both in humans and rodents, has already been proven. Yet, given the fact that salsolinol colocalizes with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kurnik-Łucka, Magdalena, Latacz, Gniewomir, Bucki, Adam, Rivera-Meza, Mario, Khan, Nadia, Konwar, Jahnobi, Skowron, Kamil, Kołaczkowski, Marcin, Gil, Krzysztof
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2023
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10586258/ https://www.ncbi.nlm.nih.gov/pubmed/37867702 http://dx.doi.org/10.1021/acsomega.3c05527

Ejemplares similares

Salsolinol—neurotoxic or Neuroprotective?
por: Kurnik-Łucka, Magdalena, et al.
Publicado: (2019)

Salsolinol Protects SH-SY5Y Cells Against MPP(+) Damage and Increases Enteric S100-Immunoreactivity in Wistar Rats
por: Kurnik-Łucka, Magdalena, et al.
Publicado: (2022)

Correction to: Salsolinol Protects SH-SY5Y Cells Against MPP(+) Damage and Increases Enteric S100‐Immunoreactivity in Wistar Rats
por: Kurnik-Łucka, Magdalena, et al.
Publicado: (2023)

Salsolinol: an Unintelligible and Double-Faced Molecule—Lessons Learned from In Vivo and In Vitro Experiments
por: Kurnik-Łucka, Magdalena, et al.
Publicado: (2017)

Salsolinol modulation of dopamine neurons
por: Xie, Guiqin, et al.
Publicado: (2013)

Neuroprotective effect of carnosine against salsolinol-induced Parkinson's disease
por: Zhao, Jun, et al.
Publicado: (2017)

Racemic Salsolinol and its Enantiomers Act as Agonists of the μ-Opioid Receptor by Activating the Gi Protein-Adenylate Cyclase Pathway
por: Berríos-Cárcamo, Pablo, et al.
Publicado: (2017)

From Ethanol to Salsolinol: Role of Ethanol Metabolites in the Effects of Ethanol
por: Peana, Alessandra T., et al.
Publicado: (2016)

Salsolinol, a catechol neurotoxin, induces oxidative modification of cytochrome c
por: Kang, Jung Hoon
Publicado: (2013)

Salsolinol and ethanol-derived excitation of dopamine mesolimbic neurons: new insights
por: Polache, Ana, et al.
Publicado: (2013)

Oxidative modification of human ceruloplasmin induced by a catechol neurotoxin, salsolinol
por: Kim, Seung-Sub, et al.
Publicado: (2016)

Synergistic Neuroprotective Effect of Endogenously-Produced Hydroxytyrosol and Synaptic Vesicle Proteins on Pheochromocytoma Cell Line against Salsolinol
por: Manzoor, Robina, et al.
Publicado: (2020)

Chronic Salsolinol Administration Prevents the Behavioral and Neurochemical Effects of l-DOPA in Rats
por: Wąsik, Agnieszka, et al.
Publicado: (2015)

Production of the Neurotoxin Salsolinol by a Gut-Associated Bacterium and Its Modulation by Alcohol
por: Villageliú, Daniel N., et al.
Publicado: (2018)

Salsolinol Facilitates Glutamatergic Transmission to Dopamine Neurons in the Posterior Ventral Tegmental Area of Rats
por: Xie, Guiqin, et al.
Publicado: (2012)

Salsolinol, an Endogenous Compound Triggers a Two-Phase Opposing Action in the Central Nervous System
por: Możdżeń, Edyta, et al.
Publicado: (2014)

Ethanol-Dependent Synthesis of Salsolinol in the Posterior Ventral Tegmental Area as Key Mechanism of Ethanol’s Action on Mesolimbic Dopamine
por: Bassareo, Valentina, et al.
Publicado: (2021)

Adaptive Modifications of Maternal Hypothalamic-Pituitary-Adrenal Axis Activity during Lactation and Salsolinol as a New Player in this Phenomenon
por: Hasiec, Malgorzata, et al.
Publicado: (2018)

Backstage of Eating Disorder—About the Biological Mechanisms behind the Symptoms of Anorexia Nervosa
por: Skowron, Kamil, et al.
Publicado: (2020)

Salsolinol Attenuates Doxorubicin-Induced Chronic Heart Failure in Rats and Improves Mitochondrial Function in H9c2 Cardiomyocytes
por: Wen, Jianxia, et al.
Publicado: (2019)

Salsolinol improves angiotensin II‑induced myocardial fibrosis in vitro via inhibition of LSD1 through regulation of the STAT3/Notch‑1 signaling pathway
por: Zhang, Xian, et al.
Publicado: (2023)

Serotonin 5-HT(6) Receptor Ligands and Butyrylcholinesterase Inhibitors Displaying Antioxidant Activity—Design, Synthesis and Biological Evaluation of Multifunctional Agents against Alzheimer’s Disease
por: Więckowski, Krzysztof, et al.
Publicado: (2022)

Gastrointestinal Dopamine in Inflammatory Bowel Diseases: A Systematic Review
por: Kurnik-Łucka, Magdalena, et al.
Publicado: (2021)

Health-Related Quality of Life in Relation to Fruit and Vegetable Intake among Polish Pharmacists
por: Kurnik-Łucka, Magdalena, et al.
Publicado: (2022)

Is the Activity-Based Anorexia Model a Reliable Method of Presenting Peripheral Clinical Features of Anorexia Nervosa?
por: Skowron, Kamil, et al.
Publicado: (2021)

Study on the effect of EMD386088, a 5-HT(6) receptor partial agonist, in enhancing the anti-immobility action of some antidepressants in rats
por: Jastrzębska-Więsek, Magdalena, et al.
Publicado: (2017)

Cardiotoxicity of Fluoropyrimidines: Epidemiology, Mechanisms, Diagnosis, and Management
por: Jurczyk, Michał, et al.
Publicado: (2021)

In Silico and In Vitro Assessment of Carbonyl Reductase 1 Inhibition Using ASP9521—A Potent Aldo-Keto Reductase 1C3 Inhibitor with the Potential to Support Anticancer Therapy Using Anthracycline Antibiotics
por: Jamrozik, Marek, et al.
Publicado: (2023)

2-(4-Fluorophenyl)-1H-benzo[d]imidazole as a Promising Template for the Development of Metabolically Robust, α1β2γ2GABA-A Receptor-Positive Allosteric Modulators
por: Marcinkowska, Monika, et al.
Publicado: (2023)

Discovery of Novel pERK1/2- or β-Arrestin-Preferring 5-HT(1A) Receptor-Biased Agonists: Diversified Therapeutic-like versus Side Effect Profile
por: Sniecikowska, Joanna, et al.
Publicado: (2020)

The Autonomic Innervation and Uterine Telocyte Interplay in Leiomyoma Formation
por: Aleksandrovych, Veronika, et al.
Publicado: (2019)

Idalopirdine – a small molecule antagonist of 5-HT(6) with therapeutic potential against obesity
por: Dudek, Magdalena, et al.
Publicado: (2015)

Structural Modeling of TRPA1 Ion Channel—Determination of the Binding Site for Antagonists
por: Gawalska, Alicja, et al.
Publicado: (2022)

Phenylalanine-Based AMPA Receptor Antagonist as the Anticonvulsant Agent with Neuroprotective Activity—In Vitro and In Vivo Studies
por: Latacz, Gniewomir, et al.
Publicado: (2022)

Metabolic carbonyl reduction of anthracyclines — role in cardiotoxicity and cancer resistance. Reducing enzymes as putative targets for novel cardioprotective and chemosensitizing agents
por: Piska, Kamil, et al.
Publicado: (2017)

Idalopirdine, a selective 5-HT(6) receptor antagonist, reduces food intake and body weight in a model of excessive eating
por: Kotańska, Magdalena, et al.
Publicado: (2018)

The Stereoselectivity and Hydrolysis Efficiency of Recombinant d-Hydantoinase from Vigna angularis Against 5-Benzylhydantoin Derivatives with Halogen and Methyl Substituents
por: Latacz, Gniewomir, et al.
Publicado: (2014)

The Search for New Anticonvulsants in a Group of (2,5-Dioxopyrrolidin-1-yl)(phenyl)Acetamides with Hybrid Structure—Synthesis and In Vivo/In Vitro Studies
por: Abram, Michał, et al.
Publicado: (2020)

In Vitro and In Silico ADME-Tox Profiling and Safety Significance of Multifunctional Monoamine Oxidase Inhibitors Targeting Neurodegenerative Diseases
por: Więckowska, Anna, et al.
Publicado: (2020)

Novel and effective synthesis protocol of AgNPs functionalized using L-cysteine as a potential drug carrier
por: Wojnicki, Marek, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_marphph7av0bodfc6dbpj2fn9m